Search research articles
Contact Us
Filters
Showing results (561-570 of 657) with videos related to
Page
of 66
Sort By:
Transboundary and Emerging Diseases
|
April 30, 2016
Bat Hunting and Bat-Human Interactions in Bangladeshi Villages: Implications for Zoonotic Disease Transmission and Bat Conservation
J J Openshaw, S Hegde, H M S Sazzad, et al.
Molecular Cell
|
June 10, 2021
Translation stress and collided ribosomes are co-activators of cGAS
Li Wan, Szymon Juszkiewicz, Daniel Blears, et al.
Nature Communications
|
September 14, 2019
The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension
Yuhua Wang, Ram Naresh Pandey, Allen J York, et al.
The Journal of Biological Chemistry
|
August 7, 2015
Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis
Mamatha Bangalore Nijaguna, Vikas Patil, Serge Urbach, et al.
Plos One
|
March 20, 2012
CRIM1 complexes with ß-catenin and cadherins, stabilizes cell-cell junctions and is critical for neural morphogenesis
Virgilio G Ponferrada, Jieqing Fan, Jefferson E Vallance, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2014
Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties
Sharath S Hegde, Adam D Hughes, Yan Chen, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2004
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria
Sharath S Hegde, Noe Reyes, Tania Wiens, et al.
Journal of Medicinal Chemistry
|
January 29, 2015
Discovery of (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate (TD-5959, GSK961081, batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and β₂ agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)
Adam D Hughes, Yan Chen, Sharath S Hegde, et al.
American Journal of Clinical Pathology
|
August 21, 2012
IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance
Balaram Thota, Sudhanshu K Shukla, Mallavarapu R Srividya, et al.
Pharmacology Research & Perspectives
|
May 9, 2018
Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues
Sharath S Hegde, M Teresa Pulido-Rios, Mark A Luttmann, et al.
Page
of 66
Search research articles
Search
Showing results (561-570 of 657) with videos related to
Sort By:
Page
of 66
Transboundary and Emerging Diseases
|
April 30, 2016
Bat Hunting and Bat-Human Interactions in Bangladeshi Villages: Implications for Zoonotic Disease Transmission and Bat Conservation
J J Openshaw, S Hegde, H M S Sazzad, et al.
Molecular Cell
|
June 10, 2021
Translation stress and collided ribosomes are co-activators of cGAS
Li Wan, Szymon Juszkiewicz, Daniel Blears, et al.
Nature Communications
|
September 14, 2019
The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension
Yuhua Wang, Ram Naresh Pandey, Allen J York, et al.
The Journal of Biological Chemistry
|
August 7, 2015
Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis
Mamatha Bangalore Nijaguna, Vikas Patil, Serge Urbach, et al.
Plos One
|
March 20, 2012
CRIM1 complexes with ß-catenin and cadherins, stabilizes cell-cell junctions and is critical for neural morphogenesis
Virgilio G Ponferrada, Jieqing Fan, Jefferson E Vallance, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 8, 2014
Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties
Sharath S Hegde, Adam D Hughes, Yan Chen, et al.
Antimicrobial Agents and Chemotherapy
|
July 27, 2004
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria
Sharath S Hegde, Noe Reyes, Tania Wiens, et al.
Journal of Medicinal Chemistry
|
January 29, 2015
Discovery of (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate (TD-5959, GSK961081, batefenterol): first-in-class dual pharmacology multivalent muscarinic antagonist and β₂ agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD)
Adam D Hughes, Yan Chen, Sharath S Hegde, et al.
American Journal of Clinical Pathology
|
August 21, 2012
IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance
Balaram Thota, Sudhanshu K Shukla, Mallavarapu R Srividya, et al.
Pharmacology Research & Perspectives
|
May 9, 2018
Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues
Sharath S Hegde, M Teresa Pulido-Rios, Mark A Luttmann, et al.
Page
of 66